| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $21.06M | - | |
| Other | 193.8K | $4.91M | - | |
| VP | 156.1K | $3.95M | - | |
| VP | 130.1K | $3.29M | - | |
| VP | 71.8K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,789 | $44.62 | $79,823.39 | -1.2% | -11.9% | - | |
| Nov 10, 2025 | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 2,566 | $44.62 | $114,492.35 | -4.0% | -11.9% | - | |
| Aug 27, 2025 | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sale+OE | 18,200 | $44.02 | $801,218.60 | -22.1% | +7.1% | - | |
| Aug 25, 2025 | Holloway Jean F49 | SVP, General Counsel | Sale+OE | 10,000 | $44.37 | $443,700.00 | -5.5% | +5.1% | - | |
| Aug 15, 2025 | MacKin James P53 | President &CEO | Sell | 12,500 | $42.32 | $528,987.50 | -1.4% | +6.5% | - | |
| Aug 12, 2025 | Holloway Jean F49 | SVP, General Counsel | Sale+OE | 23,356 | $43.01 | $1,004,609.58 | -6.2% | +2.6% | - | |
| Aug 12, 2025 | Davis John E | Chief Commercial Officer | Sale+OE | 10,802 | $43.67 | $471,755.75 | -4.9% | +2.6% | - | |
| Aug 8, 2025 | Horton Amy48 | VP, Chief Accounting Officer | Sale+OE | 7,992 | $38.49 | $307,612.08 | -5.2% | +16.0% | - | |
| Jun 17, 2025 | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 15,000 | $29.50 | $442,500.00 | -10.4% | +33.6% | -28.8% | |
| Jun 13, 2025 | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 26,132 | $28.44 | $743,131.21 | -6.9% | +49.8% | -28.8% |